When Type 1 Diabetes and Thyroid Eye Disease Occur Together: What a New Study Reveals

Graves' disease is an autoimmune condition where the body's immune system attacks the thyroid gland. Thyroid eye disease (TED) is a related condition that can cause inflammation and swelling around the eyes. Some people with Graves' disease develop thyroid eye disease as an isolated problem, while others have additional autoimmune conditions occurring at the same time—a pattern called autoimmune polyglandular syndrome.

Researchers wanted to know whether having multiple autoimmune diseases makes thyroid eye disease more severe or changes how well people respond to treatment.

Scientists reviewed medical records from 159 patients with moderate-to-severe thyroid eye disease who received high-dose intravenous steroid therapy at two Italian medical centers. They separated patients into two groups: those with Graves' disease alone (147 patients, 92.5%) and those with Graves' disease plus other autoimmune conditions (12 patients, 7.5%).

Type 1 diabetes and rheumatoid arthritis were the most common additional autoimmune diseases in the smaller group. Notably, all 12 patients with multiple autoimmune conditions were women, though this was a small subset.

When researchers compared the two groups, they found no meaningful differences in how they responded to treatment. Both groups required similar amounts of steroid medication, and both showed comparable improvement with high-dose intravenous glucocorticoid therapy. Age, smoking status, and thyroid function measures were also similar between the groups.

This suggests that having additional autoimmune diseases alongside Graves' disease did not make thyroid eye disease harder to treat in this patient population.

For people with Type 1 diabetes or other autoimmune conditions who develop Graves' disease and thyroid eye disease, this research offers some reassurance: the presence of multiple autoimmune conditions does not appear to significantly worsen outcomes or change how these eye problems respond to standard treatment.

However, the study was relatively small and focused on patients with moderate-to-severe thyroid eye disease requiring intensive therapy. More research may be needed to understand the broader relationship between multiple autoimmune conditions and thyroid eye disease in different patient groups.

Source: Frontiers in endocrinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.